• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by The Beauty Health Company (Amendment)

    2/14/24 4:10:19 PM ET
    $SKIN
    Medical/Dental Instruments
    Health Care
    Get the next $SKIN alert in real time by email
    SC 13G/A 1 beauty13ga2-02142024.htm
    SECURITIES AND EXCHANGE COMMISSION
    WASHINGTON, D.C.  20549
    SCHEDULE 13G
    (RULE 13d - 102)
    INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO 13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO 13d-2(b)
    (Amendment No. 2)*
    The Beauty Health Company
    (Name of Issuer)
    Class A Common Stock, par value $0.0001 per share
    (Title of Class of Securities)
    88331L108
    (CUSIP Number)
    December 31, 2023
    (Date of Event which Requires Filing of this Statement)
    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
    [ ]            Rule 13d-1(b)
    [x]            Rule 13d-1(c)
    [ ]            Rule 13d-1(d)
    *The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.
    The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).


    1.
    NAMES OF REPORTING PERSONS
    I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
       
     
    Luxor Capital Partners, LP
       
    2.
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
       
     
    (a)    [x]
     
    (b)    [ ]
       
    3.
    SEC USE ONLY
       
    4.
    CITIZENSHIP OR PLACE OF ORGANIZATION
       
     
    Delaware
       
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:
       
    5.
    SOLE VOTING POWER
       
     
    0
       
    6.
    SHARED VOTING POWER
       
     
    18,872
       
    7.
    SOLE DISPOSITIVE POWER
       
     
    0
       
    8.
    SHARED DISPOSITIVE POWER
       
     
    18,872
       
    9.
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
       
     
    18,872
       
    10.
    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9)
    EXCLUDES CERTAIN SHARES    [ ]
       
    11.
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
       
     
    Less than 1%
       
    12.
    TYPE OF REPORTING PERSON
       
     
    PN




    1.
    NAMES OF REPORTING PERSONS
    I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
       
     
    Luxor Capital Partners Offshore Master Fund, LP
       
    2.
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
       
     
    (a)    [x]
     
    (b)    [ ]
       
    3.
    SEC USE ONLY
       
    4.
    CITIZENSHIP OR PLACE OF ORGANIZATION
       
     
    Cayman Islands
       
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:
       
    5.
    SOLE VOTING POWER
       
     
    0
       
    6.
    SHARED VOTING POWER
       
     
    2,400
       
    7.
    SOLE DISPOSITIVE POWER
       
     
    0
       
    8.
    SHARED DISPOSITIVE POWER
       
     
    2,400
       
    9.
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
       
     
    2,400
       
    10.
    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9)
    EXCLUDES CERTAIN SHARES    [ ]
       
    11.
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
       
     
    Less than 1%
       
    12.
    TYPE OF REPORTING PERSON
       
     
    PN



    1.
    NAMES OF REPORTING PERSONS
    I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
       
     
    Luxor Capital Partners Offshore, Ltd.
       
    2.
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
       
     
    (a)    [x]
     
    (b)    [ ]
       
    3.
    SEC USE ONLY
       
    4.
    CITIZENSHIP OR PLACE OF ORGANIZATION
       
     
    Cayman Islands
       
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:
       
    5.
    SOLE VOTING POWER
       
     
    0
       
    6.
    SHARED VOTING POWER
       
     
    2,400
       
    7.
    SOLE DISPOSITIVE POWER
       
     
    0
       
    8.
    SHARED DISPOSITIVE POWER
       
     
    2,400
       
    9.
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
       
     
    2,400
       
    10.
    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9)
    EXCLUDES CERTAIN SHARES    [ ]
       
    11.
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
       
     
    Less than 1%
       
    12.
    TYPE OF REPORTING PERSON
       
     
    CO



    1.
    NAMES OF REPORTING PERSONS
    I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
       
     
    Lugard Road Capital Master Fund, LP
       
    2.
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
       
     
    (a)    [x]
     
    (b)    [ ]
       
    3.
    SEC USE ONLY
       
    4.
    CITIZENSHIP OR PLACE OF ORGANIZATION
       
     
    Cayman Islands
       
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:
       
    5.
    SOLE VOTING POWER
       
     
    0
       
    6.
    SHARED VOTING POWER
       
     
    8,602,379
       
    7.
    SOLE DISPOSITIVE POWER
       
     
    0
       
    8.
    SHARED DISPOSITIVE POWER
       
     
    8,602,379
       
    9.
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
       
     
    8,602,379
       
    10.
    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9)
    EXCLUDES CERTAIN SHARES    [ ]
       
    11.
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
       
     
    6.5%
       
    12.
    TYPE OF REPORTING PERSON
       
     
    PN


    1.
    NAMES OF REPORTING PERSONS
    I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
       
     
    LCG Holdings, LLC
       
    2.
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
       
     
    (a)    [x]
     
    (b)    [ ]
       
    3.
    SEC USE ONLY
       
    4.
    CITIZENSHIP OR PLACE OF ORGANIZATION
       
     
    Delaware
       
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:
       
    5.
    SOLE VOTING POWER
       
     
    0
       
    6.
    SHARED VOTING POWER
       
     
    21,272
       
    7.
    SOLE DISPOSITIVE POWER
       
     
    0
       
    8.
    SHARED DISPOSITIVE POWER
       
     
    21,272
       
    9.
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
       
     
    21,272
       
    10.
    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9)
    EXCLUDES CERTAIN SHARES    [ ]
       
    11.
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
       
     
    Less than 1%
       
    12.
    TYPE OF REPORTING PERSON
       
     
    OO



    1.
    NAMES OF REPORTING PERSONS
    I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
       
     
    Lugard Road Capital GP, LLC
       
    2.
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
       
     
    (a)    [x]
     
    (b)    [ ]
       
    3.
    SEC USE ONLY
       
    4.
    CITIZENSHIP OR PLACE OF ORGANIZATION
       
     
    Delaware
       
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:
       
    5.
    SOLE VOTING POWER
       
     
    0
       
    6.
    SHARED VOTING POWER
       
     
    8,602,379
       
    7.
    SOLE DISPOSITIVE POWER
       
     
    0
       
    8.
    SHARED DISPOSITIVE POWER
       
     
    8,602,379
       
    9.
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
       
     
    8,602,379
       
    10.
    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9)
    EXCLUDES CERTAIN SHARES    [ ]
       
    11.
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
       
     
    6.5%
       
    12.
    TYPE OF REPORTING PERSON
       
     
    OO


    1.
    NAMES OF REPORTING PERSONS
    I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
       
     
    Luxor Capital Group, LP
       
    2.
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
       
     
    (a)    [x]
     
    (b)    [ ]
       
    3.
    SEC USE ONLY
       
    4.
    CITIZENSHIP OR PLACE OF ORGANIZATION
       
     
    Delaware
       
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:
       
    5.
    SOLE VOTING POWER
       
     
    0
       
    6.
    SHARED VOTING POWER
       
     
    8,623,651
       
    7.
    SOLE DISPOSITIVE POWER
       
     
    0
       
    8.
    SHARED DISPOSITIVE POWER
       
     
    8,623,651
       
    9.
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
       
     
    8,623,651
       
    10.
    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9)
    EXCLUDES CERTAIN SHARES    [ ]
       
    11.
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
       
     
    6.5%
       
    12.
    TYPE OF REPORTING PERSON
       
     
    PN


    1.
    NAMES OF REPORTING PERSONS
    I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
       
     
    Luxor Management, LLC
       
    2.
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
       
     
    (a)    [x]
     
    (b)    [ ]
       
    3.
    SEC USE ONLY
       
    4.
    CITIZENSHIP OR PLACE OF ORGANIZATION
       
     
    Delaware
       
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:
       
    5.
    SOLE VOTING POWER
       
     
    0
       
    6.
    SHARED VOTING POWER
       
     
    8,623,651
       
    7.
    SOLE DISPOSITIVE POWER
       
     
    0
       
    8.
    SHARED DISPOSITIVE POWER
       
     
    8,623,651
       
    9.
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
       
     
    8,623,651
       
    10.
    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9)
    EXCLUDES CERTAIN SHARES    [ ]
       
    11.
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
       
     
    6.5%
       
    12.
    TYPE OF REPORTING PERSON
       
     
    OO



    1.
    NAMES OF REPORTING PERSONS
    I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
       
     
    Jonathan Green
       
    2.
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
       
     
    (a)    [x]
     
    (b)    [ ]
       
    3.
    SEC USE ONLY
       
    4.
    CITIZENSHIP OR PLACE OF ORGANIZATION
       
     
    United States
       
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:
       
    5.
    SOLE VOTING POWER
       
     
    0
       
    6.
    SHARED VOTING POWER
       
     
    8,602,379
       
    7.
    SOLE DISPOSITIVE POWER
       
     
    0
       
    8.
    SHARED DISPOSITIVE POWER
       
     
    8,602,379
       
    9.
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
       
     
    8,602,379
       
    10.
    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9)
    EXCLUDES CERTAIN SHARES    [ ]
       
    11.
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
       
     
    6.5%
       
    12.
    TYPE OF REPORTING PERSON
       
     
    IN


    1.
    NAMES OF REPORTING PERSONS
    I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
       
     
    Christian Leone
       
    2.
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
       
     
    (a)    [x]
     
    (b)    [ ]
       
    3.
    SEC USE ONLY
       
    4.
    CITIZENSHIP OR PLACE OF ORGANIZATION
       
     
    United States
       
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:
       
    5.
    SOLE VOTING POWER
       
     
    0
       
    6.
    SHARED VOTING POWER
       
     
    8,623,651
       
    7.
    SOLE DISPOSITIVE POWER
       
     
    0
       
    8.
    SHARED DISPOSITIVE POWER
       
     
    8,623,651
       
    9.
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
       
     
    8,623,651
       
    10.
    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9)
    EXCLUDES CERTAIN SHARES    [ ]
       
    11.
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
       
     
    6.5%
       
    12.
    TYPE OF REPORTING PERSON
       
     
    IN


    Item 1(a).
    Name of Issuer:
    The Beauty Health Company (“Issuer”)
    Item 1(b).
    Address of Issuer’s Principal Executive Offices:
    2165 Spring Street
    Long Beach, CA 90806

    Item 2.  (a) Name of Persons Filing:
    (b) Address of Principal Business Office or, if None, Residence:
    (c) Citizenship:

    The names and citizenships of the persons filing this statement on Schedule 13G are (collectively, the “Reporting Persons”):

    Luxor Capital Partners, LP (the “Onshore Fund”)
    Citizenship: Delaware

    Luxor Capital Partners Offshore Master Fund, LP (the “Offshore Master Fund”)
    Citizenship: Cayman Islands

    Luxor Capital Partners Offshore, Ltd. (the “Offshore Feeder Fund”)
    Citizenship: Cayman Islands

    Lugard Road Capital Master Fund, LP (the “Lugard Master Fund”)
    Citizenship: Cayman Islands

    LCG Holdings, LLC (“LCG Holdings”)
    Citizenship: Delaware

    Lugard Road Capital GP, LLC (“Lugard GP”)
    Citizenship: Delaware

    Luxor Capital Group, LP (“Luxor Capital Group”)
    Citizenship: Delaware

    Luxor Management, LLC (“Luxor Management”)
    Citizenship: Delaware

    Jonathan Green (“Mr. Green”)
    Citizenship: United States

    Christian Leone (“Mr. Leone”)
    Citizenship: United States


    The principal business address of each of the Onshore Fund, Luxor Capital Group, Luxor Management, Lugard GP, LCG Holdings, Mr. Green and Mr. Leone is 7 Times Square, 43rd Floor, New York, New York 10036.
    The principal business address of each of the Offshore Master Fund, the Offshore Feeder Fund and the Lugard Master Fund is c/o Maples Corporate Services Limited, P.O. Box 309, Ugland House, Grand Cayman, KY1-1104, Cayman Islands.

    Item 2(d).
    Title of Class of Securities:
    Class A common stock, par value $0.0001 per share (the “Class A Common Stock”).
    Item 2(e).
    CUSIP Number:
    88331L108

    Item 3.
    If This Statement is Filed Pursuant to Rule 13d 1(b), or 13d-2(b) or (c), Check Whether the Person Filing is a:
     
    (a)
    [ ]
    Broker or dealer registered under Section 15 of the Exchange Act.
     
    (b)
    [ ]
    Bank as defined in Section 3(a)(6) of the Exchange Act.
     
    (c)
    [ ]
    Insurance company defined in Section 3(a)(19) of the Exchange Act.
     
    (d)
    [ ]
    Investment company registered under Section 8 of the Investment Company Act.
     
    (e)
    [ ]
    Investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E).
     
    (f)
    [ ]
    Employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F).
     
    (g)
    [ ]
    Parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G).
     
    (h)
    [ ]
    Savings association as defined in Section 3(b) of the Federal Deposit Insurance Act.
     
    (i)
    [ ]
    Church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act;
     
    (j)
    [ ]
    Non-U.S. institution in accordance with Section 240.13d-1(b)(1)(ii)(J).
     
    (k)
    [ ]
    Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).  If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution: ____

    Item 4.
    Ownership.
    (a)
    Amount beneficially owned:
    As of the close of business on December 31, 2023:

    (i)
    The Onshore Fund beneficially owned 18,872 shares of Class A Common Stock, including 3,900 shares of Class A Common Stock underlying call options currently exercisable;

    (ii)
    The Offshore Master Fund beneficially owned 2,400 shares of Class A Common Stock, including 2,400 shares of Class A Common Stock underlying call options currently exercisable. The Offshore Feeder Fund, as the owner of a controlling interest in the Offshore Master Fund, may be deemed to have beneficially owned the shares of Class A Common Stock beneficially owned by the Offshore Master Fund;

    (iii)
    The Lugard Master Fund beneficially owned 8,602,379 shares of Class A Common Stock, including 1,536,512 shares of Class A Common Stock issuable upon conversion of convertible notes and 493,700 shares of Class A Common Stock underlying call options currently exercisable;



    (vi)
    LCG Holdings, as the general partner of the Onshore Fund and the Offshore Master Fund may be deemed to have beneficially owned the 21,272 shares of Class A Common Stock beneficially owned by the Onshore Fund and the Offshore Master Fund;

    (vii)
    Lugard GP, as the general partner of the Lugard Master Fund, may be deemed to have beneficially owned the 8,602,379 shares of Class A Common Stock beneficially owned by the Lugard Master Fund;

    (viii)
    Mr. Green, as a managing member of Lugard GP, may be deemed to have beneficially owned the 8,602,379 shares of Class A Common Stock beneficially owned by Lugard GP.

    (ix)
    Luxor Capital Group, as the investment manager of the Onshore Fund, the Offshore Feeder Fund and the Offshore Master Fund (collectively, the “Funds”), may be deemed to have beneficially owned the 8,623,651 shares of Class A Common Stock beneficially owned by the Funds;

    (x)
    Luxor Management, as the general partner of Luxor Capital Group, may be deemed to have beneficially owned the 8,623,651 shares of Class A Common Stock beneficially owned by Luxor Capital Group; and

    (xi)
    Mr. Leone, as the managing member of Luxor Management, may be deemed to have beneficially owned the 8,623,651 shares of Class A Common Stock beneficially owned by Luxor Management.
    (b)
    Percent of Class:
    As of the close of business on December 31, 2023, the Reporting Persons may be deemed to have beneficially owned 8,623,651 shares of the Issuer’s Class A Common Stock or 6.5% of the Issuer’s Class A Common Stock outstanding, which percentage was calculated based on 131,266,839 shares of the Issuer’s Class A Common Stock outstanding as of November 13, 2023, as per the information reported in the Issuer’s Prospectus filed on November 14, 2023 (plus, with respect to certain Reporting Persons, the number of Class A Common Stock underlying currently exercisable convertible notes held by such Reporting Persons as indicated in Item 4(a) above). Specifically, as of the close of business on December 31, 2023 each Reporting Person beneficially owned such percentage as reflected on Item 11 of the applicable Cover Page hereto.
    (c)
    Number of shares as to which such person has:

    (i)
    Sole power to vote or to direct the vote of Class A Common Stock:
    See Cover Pages Items 5-9.

    (ii)
    Shared power to vote or to direct the vote of Class A Common Stock:
    See Cover Pages Items 5-9.

    (iii)
    Sole power to dispose or to direct the disposition of Class A Common Stock:
    See Cover Pages Items 5-9.

    (iv)
    Shared power to dispose or to direct the disposition of Class A Common Stock:
    See Cover Pages Items 5-9.
    Item 5.
    Ownership of Five Percent or Less of a Class.
    If this statement is being filed to report the fact that as of the date hereof the Reporting Persons have ceased to be the beneficial owner of more than five percent of the class of securities, check the following [  ].

    Item 6.
    Ownership of More than Five Percent on Behalf of Another Person.
    Not applicable.
    Item 7.
    Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company.
    Not applicable.
    Item 8.
    Identification and Classification of Members of the Group.
    See Exhibit A.
    Item 9.
    Notice of Dissolution of Group.
    Not applicable.
    Item 10.
    Certification.
    By signing below each of the undersigned certifies that, to the best of his or its knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.


    SIGNATURES
    After reasonable inquiry and to the best of its knowledge and belief, each of the undersigned certifies that the information with respect to it set forth in this statement is true, complete, and correct.
    Dated:  February 14, 2024
    LUXOR CAPITAL PARTNERS, LP
     
       
    By: LCG Holdings, LLC, as General Partner
     
       
     
    By:
    /s/ Norris Nissim
     
       
    Norris Nissim,
     
       
    General Counsel
     


    LUXOR CAPITAL PARTNERS OFFSHORE MASTER FUND, LP
     
       
    By: LCG Holdings, LLC, as General Partner
     
       
     
    By:
    /s/ Norris Nissim
     
       
    Norris Nissim,
     
       
    General Counsel
     


    LUXOR CAPITAL PARTNERS OFFSHORE, LTD.
     
       
    By: Luxor Capital Group, LP, as investment manager
     
       
     
    By:
    /s/ Norris Nissim
     
       
    Norris Nissim,
     
       
    General Counsel
     
     
     
    LUGARD ROAD CAPITAL MASTER FUND, LP
     
       
    By: Lugard Road Capital GP, LLC, as General Partner
     
       
     
    By:
    /s/ Norris Nissim
     
       
    Norris Nissim,
     
       
    General Counsel
     


    LUXOR CAPITAL GROUP, LP
     
       
    By: Luxor Management, LLC, as General Partner
     
       
     
    By:
    /s/ Norris Nissim
     
       
    Norris Nissim,
     
       
    General Counsel
     



    LCG HOLDINGS, LLC
     
       
     
    By:
    /s/ Norris Nissim
     
       
    Norris Nissim,
     
       
    General Counsel
     


    LUGARD ROAD CAPITAL GP, LLC
     
       
     
    By:
    /s/ Norris Nissim
     
       
    Norris Nissim,
     
       
    General Counsel
     


    LUXOR MANAGEMENT, LLC
     
       
     
    By:
    /s/ Norris Nissim
     
       
    Norris Nissim,
     
       
    General Counsel
     


       
    /s/ Norris Nissim
     
    NORRIS NISSIM, as Agent for Jonathan Green
     

       
    /s/ Norris Nissim
     
    NORRIS NISSIM, as Agent for Christian Leone
     



    EXHIBIT A
    JOINT FILING AGREEMENT
    The undersigned hereby agree that the statement on Schedule 13G/A with respect to the Class A Common Stock of The Beauty Health Company dated February 14, 2024, and any further amendments thereto signed by each of the undersigned shall be, filed on behalf of each of the undersigned pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended.
    Dated:  February 14, 2024
    LUXOR CAPITAL PARTNERS, LP
     
       
    By: LCG Holdings, LLC, as General Partner
     
       
     
    By:
    /s/ Norris Nissim
     
       
    Norris Nissim,
     
       
    General Counsel
     


    LUXOR CAPITAL PARTNERS OFFSHORE MASTER FUND, LP
     
       
    By: LCG Holdings, LLC, as General Partner
     
       
     
    By:
    /s/ Norris Nissim
     
       
    Norris Nissim,
     
       
    General Counsel
     


    LUXOR CAPITAL PARTNERS OFFSHORE, LTD.
     
       
    By: Luxor Capital Group, LP, as investment manager
     
       
     
    By:
    /s/ Norris Nissim
     
       
    Norris Nissim,
     
       
    General Counsel
     
     
     
    LUGARD ROAD CAPITAL MASTER FUND, LP
     
       
    By: Lugard Road Capital GP, LLC, as General Partner
     
       
     
    By:
    /s/ Norris Nissim
     
       
    Norris Nissim,
     
       
    General Counsel
     



    LUXOR CAPITAL GROUP, LP
     
       
    By: Luxor Management, LLC, as General Partner
     
       
     
    By:
    /s/ Norris Nissim
     
       
    Norris Nissim,
     
       
    General Counsel
     


    LCG HOLDINGS, LLC
     
       
     
    By:
    /s/ Norris Nissim
     
       
    Norris Nissim,
     
       
    General Counsel
     


    LUGARD ROAD CAPITAL GP, LLC
     
       
     
    By:
    /s/ Norris Nissim
     
       
    Norris Nissim,
     
       
    General Counsel
     


    LUXOR MANAGEMENT, LLC
     
       
     
    By:
    /s/ Norris Nissim
     
       
    Norris Nissim,
     
       
    General Counsel
     


       
    /s/ Norris Nissim
     
    NORRIS NISSIM, as Agent for Jonathan Green
     

       
    /s/ Norris Nissim
     
    NORRIS NISSIM, as Agent for Christian Leone
     


    EXHIBIT B
    POWER OF ATTORNEY
    The undersigned hereby makes, constitutes and appoints each of Norris Nissim, Adam Miller and Virgil Alagon as the undersigned’s true and lawful authorized representative, attorney-in-fact and agent, each with the power individually to execute for and on behalf of the undersigned and to file with and deliver to the United States Securities and Exchange Commission and any other authority or party required or entitled to receive the same: (a) any Forms 3, 4 and 5, and any amendments thereto, in accordance with Section 16(a) of the Securities Exchange Act of 1934, as amended (the “1934 Act”), and the rules promulgated thereunder; and (b) any Schedule 13D or Schedule 13G, and any amendments thereto, on behalf of the undersigned in accordance with Section 13 of the 1934 Act and the rules promulgated thereunder.
    The undersigned also hereby grants to each such attorney-in-fact the full power and authority to do and perform all and every act and thing whatsoever requisite, necessary and proper to be done in the exercise of any of the rights and powers herein granted, hereby ratifying and confirming all that such attorney-in-fact shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that each of the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, is not assuming any of the undersigned's responsibilities to comply with Section 16 or Section 13 of the 1934 Act or any other provision of the 1934 Act or the rules promulgated thereunder.
    This Power of Attorney shall remain in full force and effect until earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact.
    IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of November 6, 2017.
    /s/ Christian Leone
    ACKNOWLEDGEMENT IN NEW YORK STATE
    STATE OF NEW YORK
    )
       
    COUNTY OF NEW YORK
    )

    On November 6, 2017 before me, the undersigned personally appeared, Christian Leone, personally known to me or proved to me on the basis of satisfactory evidence to be the individual whose name is subscribed to the within instrument and acknowledged to me that he executed the same in his capacity, and that by his signature on the instrument, the individual, or the person upon behalf of which the individual acted, executed the instrument.
     
    /s/ Clare Rosenbalm
     
    Name: Clare Rosenbalm
     
    Notary Public, State of NY
     
    License #: 01RO6364701



    Commission Expires: September 18, 2021




    POWER OF ATTORNEY
    The undersigned hereby makes, constitutes and appoints each of Norris Nissim, Adam Miller and Virgil Alagon as the undersigned’s true and lawful authorized representative, attorney-in-fact and agent, each with the power individually to execute for and on behalf of the undersigned and to file with and deliver to the United States Securities and Exchange Commission and any other authority or party required or entitled to receive the same: (a) any Forms 3, 4 and 5, and any amendments thereto, in accordance with Section 16(a) of the Securities Exchange Act of 1934, as amended (the “1934 Act”), and the rules promulgated thereunder; and (b) any Schedule 13D or Schedule 13G, and any amendments thereto, on behalf of the undersigned in accordance with Section 13 of the 1934 Act and the rules promulgated thereunder.
    The undersigned also hereby grants to each such attorney-in-fact the full power and authority to do and perform all and every act and thing whatsoever requisite, necessary and proper to be done in the exercise of any of the rights and powers herein granted, hereby ratifying and confirming all that such attorney-in-fact shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that each of the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, is not assuming any of the undersigned's responsibilities to comply with Section 16 or Section 13 of the 1934 Act or any other provision of the 1934 Act or the rules promulgated thereunder.
    This Power of Attorney shall remain in full force and effect until earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact.
    IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of November 6, 2017.
    /s/ Jonathan Green
    ACKNOWLEDGEMENT IN NEW YORK STATE
    STATE OF NEW YORK
    )
       
    COUNTY OF NEW YORK
    )

    On November 6, 2017 before me, the undersigned personally appeared, Jonathan Green, personally known to me or proved to me on the basis of satisfactory evidence to be the individual whose name is subscribed to the within instrument and acknowledged to me that he executed the same in his capacity, and that by his signature on the instrument, the individual, or the person upon behalf of which the individual acted, executed the instrument.
     
    /s/ Clare Rosenbalm
     
    Name: Clare Rosenbalm
     
    Notary Public, State of NY
     
    License #: 01RO6364701



    Commission Expires: September 18, 2021



    Get the next $SKIN alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $SKIN

    DatePrice TargetRatingAnalyst
    11/15/2023$11.00 → $1.50Buy → Hold
    Jefferies
    11/14/2023$10.00 → $2.50Buy → Hold
    Canaccord Genuity
    11/14/2023Neutral → Underweight
    JP Morgan
    11/14/2023$12.00 → $2.00Overweight → Underweight
    Piper Sandler
    11/14/2023$9.00 → $2.50Outperform → Market Perform
    TD Cowen
    11/14/2023Buy → Hold
    The Benchmark Company
    11/14/2023Mkt Perform → Underperform
    Raymond James
    11/14/2023Outperform → Mkt Perform
    William Blair
    More analyst ratings

    $SKIN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chairman Saunders Brent L bought $43,686 worth of shares (40,450 units at $1.08), increasing direct ownership by 0.69% to 5,921,769 units (SEC Form 4)

      4 - Beauty Health Co (0001818093) (Issuer)

      8/13/24 5:00:11 PM ET
      $SKIN
      Medical/Dental Instruments
      Health Care

    $SKIN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • The Beauty Health Company downgraded by Jefferies with a new price target

      Jefferies downgraded The Beauty Health Company from Buy to Hold and set a new price target of $1.50 from $11.00 previously

      11/15/23 7:13:27 AM ET
      $SKIN
      Medical/Dental Instruments
      Health Care
    • The Beauty Health Company downgraded by JP Morgan

      JP Morgan downgraded The Beauty Health Company from Neutral to Underweight

      11/14/23 7:45:38 AM ET
      $SKIN
      Medical/Dental Instruments
      Health Care
    • The Beauty Health Company downgraded by Canaccord Genuity with a new price target

      Canaccord Genuity downgraded The Beauty Health Company from Buy to Hold and set a new price target of $2.50 from $10.00 previously

      11/14/23 7:45:38 AM ET
      $SKIN
      Medical/Dental Instruments
      Health Care

    $SKIN
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Hydrafacial Unveils New HydraFillic with Pep9™ Skin Booster For Fine Line & Wrinkles

      LONG BEACH, Calif., June 10, 2025 (GLOBE NEWSWIRE) -- The Beauty Health Company (NASDAQ:SKIN), home to flagship brand Hydrafacial™, today announced the launch of their latest innovation, the Hydrafacial HydraFillic with Pep9™ Booster. Formulated with a new proprietary complex of nine peptides, this advanced restorative skin booster is clinically proven to visibly improve the appearance of fine lines and wrinkles, deeply hydrate, and help strengthen the skin barrier1 – revealing visually firmer, more youthful-looking complexion. The debut of this new booster reflects the Company's commitment to delivering the iconic Hydrafacial glow and continuing to advance non-invasive aesthetic treatment

      6/10/25 8:00:00 AM ET
      $SKIN
      Medical/Dental Instruments
      Health Care
    • BeautyHealth Surpasses 35,000 Hydrafacial Devices Worldwide Reflecting Growing Consumer Demand for Clinically Proven Skin Health Treatments

      LONG BEACH, Calif., June 04, 2025 (GLOBE NEWSWIRE) -- The BeautyHealth Company (NASDAQ:SKIN), home to flagship brand Hydrafacial™, recently achieved a major milestone with 35,000 Hydrafacial devices installed worldwide, reinforcing its market leadership in the hydradermabrasion category it pioneered. This accomplishment highlights the Hydrafacial treatment's continued global demand, fueled by strong brand awareness, and growing consumer preferences for non-invasive, results-driven skin health treatments. "With providers delivering approximately 5 million Hydrafacial treatments last year1, our position as one of the most in-demand professional skin health treatments is clear," said Beaut

      6/4/25 8:00:00 AM ET
      $SKIN
      Medical/Dental Instruments
      Health Care
    • The Beauty Health Company Announces Convertible Debt Refinancing

      LONG BEACH, Calif., May 21, 2025 (GLOBE NEWSWIRE) -- The Beauty Health Company (NASDAQ:SKIN), home to flagship brand Hydrafacial™, today announced that it entered into privately negotiated exchange agreements (the "Exchange Agreements") with certain holders (the "Exchanging Holders") of the Company's outstanding 1.25% convertible senior notes due 2026 (the "Existing Notes"). "Our refinancing marks a critical step in strengthening our financial position and extending a portion of our debt maturity, giving us greater flexibility to invest in long-term, profitable growth," said BeautyHealth Chief Executive Officer Marla Beck. "With a robust pipeline of innovation and bold brand initiatives,

      5/21/25 8:00:00 AM ET
      $SKIN
      Medical/Dental Instruments
      Health Care

    $SKIN
    SEC Filings

    See more
    • The Beauty Health Company filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

      8-K - Beauty Health Co (0001818093) (Filer)

      6/17/25 4:03:11 PM ET
      $SKIN
      Medical/Dental Instruments
      Health Care
    • The Beauty Health Company filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Unregistered Sales of Equity Securities, Financial Statements and Exhibits

      8-K - Beauty Health Co (0001818093) (Filer)

      5/27/25 5:19:53 PM ET
      $SKIN
      Medical/Dental Instruments
      Health Care
    • The Beauty Health Company filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - Beauty Health Co (0001818093) (Filer)

      5/21/25 4:13:53 PM ET
      $SKIN
      Medical/Dental Instruments
      Health Care

    $SKIN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Gruber Desiree was granted 73,051 shares, increasing direct ownership by 61% to 192,565 units (SEC Form 4)

      4 - Beauty Health Co (0001818093) (Issuer)

      6/18/25 4:34:50 PM ET
      $SKIN
      Medical/Dental Instruments
      Health Care
    • Chairman Saunders Brent L was granted 73,051 shares, increasing direct ownership by 1% to 5,994,820 units (SEC Form 4)

      4 - Beauty Health Co (0001818093) (Issuer)

      6/18/25 4:34:00 PM ET
      $SKIN
      Medical/Dental Instruments
      Health Care
    • Director Kerrick Michelle C. was granted 73,051 shares, increasing direct ownership by 63% to 189,813 units (SEC Form 4)

      4 - Beauty Health Co (0001818093) (Issuer)

      6/18/25 4:32:58 PM ET
      $SKIN
      Medical/Dental Instruments
      Health Care

    $SKIN
    Leadership Updates

    Live Leadership Updates

    See more
    • The Beauty Health Company Strengthens Commercial Leadership Team with Chief Revenue Officer and Chief Marketing Officer Appointments

      The Beauty Health Company (NASDAQ:SKIN), home to flagship brand Hydrafacial, today announced the appointment of two accomplished industry executives to its commercial leadership team. Ron Menezes will join Beauty Health as Chief Revenue Officer and Carrie Caulkins will join the Company as Chief Marketing Officer, effective October 15, 2024, with both reporting to the Company's Chief Executive Officer, Marla Beck. Mr. Menezes assumes his new role from Dan ("Doc") Watson, who is leaving Beauty Health and will assist with the transition through year-end. Ms. Caulkins fills an open position. Marla Beck commented on the appointments, "We are thrilled to welcome Ron and Carrie to the executive t

      10/15/24 4:10:00 PM ET
      $SKIN
      Medical/Dental Instruments
      Health Care
    • BeautyHealth Names Sheri Lewis as Chief Supply Chain and Operations Officer

      The Beauty Health Company (NASDAQ:SKIN), home to flagship brand Hydrafacial, today announced that it has appointed Sheri Lewis as Chief Supply Chain and Operations Officer, effective immediately. Ms. Lewis will report to BeautyHealth's President and Chief Executive Officer, Marla Beck. "Sheri is a talented and deeply experienced executive who brings decades of valuable global operations expertise to BeautyHealth as we chart the future of the Company," said Marla Beck, BeautyHealth President and Chief Executive Officer. "The Board of Directors and I are confident that her deep industry experience across global supply chain and operations will play a critical role in advancing our strategic

      4/9/24 4:10:00 PM ET
      $SKIN
      Medical/Dental Instruments
      Health Care
    • BeautyHealth Announces Appointment Of Marla Beck As Chief Executive Officer

      The Beauty Health Company (NASDAQ:SKIN), home to flagship brand Hydrafacial, today announced its Board of Directors has unanimously approved Marla Beck as the Company's permanent President and Chief Executive Officer. Ms. Beck has been Interim CEO since November 20, 2023, in addition to serving on the Company's Board of Directors, which she will continue to do going forward. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240312423257/en/SKIN) (Photo: Business Wire)">Marla Beck, President and Chief Executive Officer, The Beauty Health Company (NASDAQ:SKIN) (Photo: Business Wire) "Over the past few months, the Board has undertaken

      3/12/24 4:05:00 PM ET
      $SKIN
      Medical/Dental Instruments
      Health Care

    $SKIN
    Financials

    Live finance-specific insights

    See more
    • BeautyHealth Reports First Quarter 2025 Financial Results

      LONG BEACH, Calif., May 08, 2025 (GLOBE NEWSWIRE) -- The Beauty Health Company (NASDAQ:SKIN) ("BeautyHealth" or the "Company"), home to flagship brand Hydrafacial, today announced financial results for the first quarter ended March 31, 2025 ("Q1 2025"). "Our first quarter results reflect strong execution and continued momentum in our transformation strategy," said CEO Marla Beck. "We exceeded both revenue and adjusted EBITDA guidance, driven by gross profit growth and meaningful cost efficiencies. Despite macroeconomic pressures that impacted device sales, consumables revenue remained resilient, reinforcing the strength of our recurring revenue model and sustained consumer dem

      5/8/25 4:05:00 PM ET
      $SKIN
      Medical/Dental Instruments
      Health Care
    • BeautyHealth to Report First Quarter 2025 Financial Results on May 8, 2025

      LONG BEACH, Calif., April 29, 2025 (GLOBE NEWSWIRE) -- The Beauty Health Company (NASDAQ:SKIN), home to flagship brand Hydrafacial™, today announced it will report first quarter 2025 financial results after market close on Thursday, May 8, 2025. The Company will host an investor conference call at 4:30 p.m. Eastern Time, following a press release detailing the results. A live webcast of the call can be accessed on the Company's investor relations website at https://investors.beautyhealth.com, along with supporting materials. A recording of the call will become available on the site approximately three hours after its conclusion. Disclosure InformationThe Beauty Health Company announces m

      4/29/25 4:00:00 PM ET
      $SKIN
      Medical/Dental Instruments
      Health Care
    • BeautyHealth Reports Full Year and Fourth Quarter 2024 Financial Results

      LONG BEACH, Calif., March 12, 2025 (GLOBE NEWSWIRE) -- The Beauty Health Company (NASDAQ:SKIN) ("BeautyHealth"), home to flagship brand Hydrafacial, today announced financial results for the fourth quarter ended December 31, 2024 ("Q4 2024"). "In Q4 2024, we continued to strengthen our financial position, exceeding the high end of our guidance for both net sales and adjusted EBITDA," said CEO Marla Beck. "We increased consumable sales, expanded our gross margins and continued to reduce our operating expenses, delivering $9 million of adjusted EBITDA in the quarter. We now have over 34,000 global delivery systems serving our large provider base." "In 2025, we are focused on deepening

      3/12/25 4:05:00 PM ET
      $SKIN
      Medical/Dental Instruments
      Health Care

    $SKIN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by The Beauty Health Company

      SC 13G/A - Beauty Health Co (0001818093) (Subject)

      11/14/24 4:16:27 PM ET
      $SKIN
      Medical/Dental Instruments
      Health Care
    • Amendment: SEC Form SC 13G/A filed by The Beauty Health Company

      SC 13G/A - Beauty Health Co (0001818093) (Subject)

      11/14/24 11:27:23 AM ET
      $SKIN
      Medical/Dental Instruments
      Health Care
    • Amendment: SEC Form SC 13G/A filed by The Beauty Health Company

      SC 13G/A - Beauty Health Co (0001818093) (Subject)

      11/14/24 11:03:00 AM ET
      $SKIN
      Medical/Dental Instruments
      Health Care